Degarelix is a third generation antagonist of luteinizing hormone-releasing hormone (LHRH, also termed gonadotropin-releasing hormone) for the first-line treatment of androgen-dependent advanced prostate cancer.
Molecular Weight:
1632.26
Purity:
>99.5%
CAS Number:
[214766-78-6]
Formula:
C82H103ClN18O16
Target:
LHRH/GnRH
* VAT and and shipping costs not included. Errors and price changes excepted